Project Grant HT94252310136
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University received a $2,455,671.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop an AAV-based gene therapy for amyotrophic lateral sclerosis (ALS). The award, effective June 1, 2024 through May 31, 2027, will enable Johns Hopkins to conduct innovative biomedical research and advance therapeutic solutions for this neurological disorder. The federal grant funding supports the university's...
The Department of the Army Medical Command awarded The Johns Hopkins University a $982,500 project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting M6A Dysregulation as a Novel Therapeutic Strategy for C9ORF72-ALS". The award period is May 1, 2024 to April 30, 2026. This research aims to develop new treatments for the neurodegenerative disease amyotrophic lateral sclerosis (ALS), with a focus on the C9ORF72 genetic...
The Johns Hopkins University was awarded an $818,750 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support research into RNA-based modulation of TDP-43 mislocalization in ALS/FTD with uridine analogs from September 15, 2022 to September 14, 2024. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This $931,500 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports The Johns Hopkins University's research to develop a RIPK2 inhibitor for the treatment of amyotrophic lateral sclerosis (ALS). The award, effective July 1, 2025 through June 30, 2027, will fund the university's efforts to advance this novel therapeutic approach to addressing ALS, a debilitating neurodegenerative disease. As a leading academic...
This $1,137,301 federal Project Grant awarded by the Defense Health Agency on July 1, 2024 supports The Johns Hopkins University's work on "MULTI-MODAL, REMOTE TRACKING OF ALS PROGRESSION USING NOVEL DIGITAL BIOMARKERS" through June 30, 2026. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The project aims to develop...
This federal Project Grant award of $798,272.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program is funding research by The Johns Hopkins University to test the use of Wnt inhibitors as a therapeutic to reverse TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
This Project Grant award, valued at $319,240.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research by The Johns Hopkins University to characterize microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This basic and applied biomedical research aims to transform healthcare for military service members and the broader public by advancing the understanding...